Get the Weekly Intelligence Brief — top committee picks every Sunday.
RELY · NASDAQ · STOCK

Remitly Global (RELY) Stock Analysis

Technology Updated October 14, 2026
$24.20
52W $12.08 – $27.48
65/100
$5.00B
16.4
0.39
AI Committee Verdict
Buy
65/100
Conviction: Moderate · 67% agreement · 6 analysts
+5.1%
-4.9%
1.04:1
Moderate

Is RELY Bullish or Bearish?

Bullish. Innellis AI committee rates Remitly Global, Inc. (RELY) Buy with a composite score of 65/100 , based on 6 analysts with 67% agreement. Last updated October 14, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +9.52 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -10.48 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 2130.0% yoy. Portfolio Manager remains cautious — 2 existing position pair(s) are highly correlated already. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 33.0% shows genuine earnings power backing the valuation — Value
  • EPS growing 2130.0% YoY — Growth
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Low leverage (debt-to-equity 0.18) -- balance sheet can absorb a shock — Risk
Bear Case
  • Bollinger bandwidth of 19.1% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 14, 2026
Overall Committee Score
65/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 4%
of 287 Technology peers
Value Analyst bullish
65 / 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 33.0% shows genuine earnings power backing the valuation
Growth Analyst bullish
79 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 2130.0% YoY
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst neutral
58 / 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.18) -- balance sheet can absorb a shock
− Bollinger bandwidth of 19.1% signals elevated volatility
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
68 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.33 across 6 articles, 14d)
Portfolio Manager bearish
35 / 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 67.7 to 65.5.

Analyst-level changes:
  • Macro Analyst: score 80->65 (-15).
  • News Analyst: +1 bullish signal(s).
  • Portfolio Manager: score 30->35 (+5).
  • Risk Analyst: +1 bearish signal(s).

Comparing 2026-10-13 to 2026-10-14 (1 day apart).

Technical Analysis

RSI (14)
58.8
Neutral
MACD Histogram
0.319
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$22.34
Resistance
$24.70
Bollinger %B
0.79
Inside Bands
Price vs Moving Averages
EMA 9
$23.22 Above
EMA 21
$22.94 Above
EMA 50
$23.14 Above
EMA 200
$21.13 Above

Fundamental Analysis

Valuation
83
Growth
94
Profitability
67
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 16.4×
P/B Ratio 4.45×
PEG Ratio 0.01
Dividend Yield 0.00%
52W High $27.48
52W Low $12.08
Quality & Growth
ROE 781.9%
ROA 465.7%
Gross Margin 6001.2%
Operating Margin 1010.1%
Revenue Growth YoY —
Debt / Equity 0.03
AI Fundamental Assessment
P/E ratio of 16.4 (inexpensive relative to a 15-40x range); Price-to-book of 4.4x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 7.8%; Return on assets of 4.7%; Net margin of 16.9%; Gross margin of 60.0%; Current ratio of 3.18 (healthy short-term liquidity); Debt-to-equity of 0.03; Free cash flow per share is positive (2.07); Most recent quarter beat estimates by 601.4%; 4 consecutive earnings beats; EPS growth accelerating (+21.1% -> +304.3% QoQ); Analyst estimates rising over recent quarters
Get the Full RELY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime